Randox Laboratories Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Randox Laboratories Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010926
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers diagnostic, prognostic and predictive solutions for cardiovascular disease, infectious disease and cancer. Randox also provides testing services. Its products find application in various areas including hospital laboratories; clinical, research and molecular laboratories; forensic toxicology laboratories; food testing laboratories; and life sciences and veterinary laboratories. The company has its manufacturing and research and development (R&D) facilities in Ireland, India, the UK and the US. Randox is headquartered in Antrim, the UK.

Randox Laboratories Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Randox Laboratories Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Randox Laboratories Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Randox Laboratories Ltd, Medical Equipment, Deal Details 10
Partnerships 10
University of Surrey Enters Into Licensing Agreement With Randox For Engrailed-2 Biomarker 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 11
Aterovax Enters Into Licensing Agreement With Randox For sPLA2 Test 12
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 13
Randox Laboratories Ltd – Key Competitors 14
Randox Laboratories Ltd – Key Employees 15
Randox Laboratories Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Product News 18
Jan 06, 2017: Randox supports calls from Oxford University for more accurate diagnosis of diabetes following report warning 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Randox Laboratories Ltd, Medical Equipment, Key Facts, 2015 2
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Randox Laboratories Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Randox Laboratories Ltd, Deals By Market, 2011 to YTD 2017 8
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
University of Surrey Enters Into Licensing Agreement With Randox For Engrailed-2 Biomarker 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 11
Aterovax Enters Into Licensing Agreement With Randox For sPLA2 Test 12
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 13
Randox Laboratories Ltd, Key Competitors 14
Randox Laboratories Ltd, Key Employees 15
Randox Laboratories Ltd, Other Locations 16
Randox Laboratories Ltd, Subsidiaries 16

★海外企業調査レポート[Randox Laboratories Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kazanorgsintez (KZOS):企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dana Inc:企業の戦略・SWOT・財務分析
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Titan Medical Inc (TMD)-医療機器分野:企業M&A・提携分析
    Summary Titan Medical Inc (Titan) is a development stage company that designs and develops a robotic surgical system for application in minimally invasive surgery (MIS). The company's lead product candidate, single port robotic (SPORT) surgical system is a single-incision robotic surgical system tha …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務情報
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Insperity Inc (NSP):企業の財務・戦略的SWOT分析
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ION Geophysical Corp (IO):石油・ガス:M&Aディール及び事業提携情報
    Summary ION Geophysical Corp (ION) is a provider of seismic solutions. It offers geoscience products, services and solutions to the global oil and gas industry. The company acquires, process and interpret data from seismic surveys in regional data programs, which become part of the multi-client data …
  • Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Feilo Sylvania Europe Ltd:企業の戦略的SWOT分析
    Feilo Sylvania Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nippon Life Insurance Company:戦略・SWOT・企業財務分析
    Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Servier Canada Inc-製薬・医療分野:企業M&A・提携分析
    Summary Servier Canada Inc (SCI), a subsidiary of Les Laboratoires Servier SAS is a manufacturer and distributor of generic and ethical products. The company’s products include perindopril erbumine tablets, perindopril erbumine indaparride tablets, glidazide modified release tablets, glidazide table …
  • Club Mediterranee SA:戦略・SWOT・企業財務分析
    Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report Summary Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • KineMed Inc-医療機器分野:企業M&A・提携分析
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • New Standard Energy Ltd (NSE):石油・ガス:M&Aディール及び事業提携情報
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • The Co-Operators Group Limited:企業の戦略的SWOT分析
    The Co-Operators Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Henry Schein Inc (HSIC):医療機器:M&Aディール及び事業提携情報
    Summary Henry Schein Inc (Henry Schein) is a distributor of medical, dental and veterinary products including vaccines, medicines and equipment. Its product portfolio consists of dental, medical and animal health products, software and technology and other value-added services, besides financial ser …
  • Trident Limited:戦略・SWOT・企業財務分析
    Trident Limited - Strategy, SWOT and Corporate Finance Report Summary Trident Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Oval Medical Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd is a medical device company that develops revolutionary autoinjectors. The company designs and develops drug delivery devices and drug delivery solutions. Its technologies are used to deliver viscous formulations and sensi …
  • Caisse de depot et placement du Quebec:企業の戦略・SWOT・財務情報
    Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report Summary Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆